These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 20970608

  • 21. Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation?
    Zeier M, Van Der Giet M.
    Transpl Int; 2011 Jan; 24(1):30-42. PubMed ID: 20642495
    [Abstract] [Full Text] [Related]

  • 22. Onychopathy induced by temsirolimus, a mammalian target of rapamycin inhibitor.
    Peuvrel L, Quéreux G, Brocard A, Saint-Jean M, Dréno B.
    Dermatology; 2012 Jan; 224(3):204-8. PubMed ID: 22614575
    [Abstract] [Full Text] [Related]

  • 23. Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation.
    Somers MJ, Paul E.
    J Clin Pharmacol; 2015 Apr; 55(4):368-76. PubMed ID: 25402866
    [Abstract] [Full Text] [Related]

  • 24. Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma.
    Nozawa M, Ohzeki T, Tamada S, Hongo F, Anai S, Fujimoto K, Miki T, Nakatani T, Fukasawa S, Uemura H.
    Int J Clin Oncol; 2015 Aug; 20(4):790-5. PubMed ID: 25342378
    [Abstract] [Full Text] [Related]

  • 25. Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer.
    Peddi PF, Shatsky RA, Hurvitz SA.
    Cancer Treat Rev; 2014 Mar; 40(2):320-6. PubMed ID: 24011786
    [Abstract] [Full Text] [Related]

  • 26. Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients.
    Sathya CJ, Sheshgiri R, Prodger J, Tumiati L, Delgado D, Ross HJ, Rao V.
    Transpl Int; 2010 Jun; 23(6):641-8. PubMed ID: 20102553
    [Abstract] [Full Text] [Related]

  • 27. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E.
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Everolimus: side effect profile and management of toxicities in breast cancer.
    Paplomata E, Zelnak A, O'Regan R.
    Breast Cancer Res Treat; 2013 Aug; 140(3):453-62. PubMed ID: 23907751
    [Abstract] [Full Text] [Related]

  • 31. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
    Celik S, Doesch A, Erbel C, Blessing E, Ammon K, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2008 Jul 27; 86(2):245-50. PubMed ID: 18645486
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.
    Tenderich G, Fuchs U, Zittermann A, Muckelbauer R, Berthold HK, Koerfer R.
    Clin Transplant; 2007 Jul 27; 21(4):536-43. PubMed ID: 17645716
    [Abstract] [Full Text] [Related]

  • 36. Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options.
    Schrader J, Sterneck M, Klose H, Lohse AW, Nashan B, Fischer L.
    Transpl Int; 2010 Jan 27; 23(1):110-3. PubMed ID: 19497063
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.